Rosemary Acid
Also known as: Rosmarinic acid, RA, Rosemary acid derivative, Rosemary polyphenol
Overview
Rosmarinic acid is a naturally occurring polyphenolic compound predominantly found in rosemary (*Rosmarinus officinalis*) and other herbs like basil, sage, and mint. It is chemically classified as an ester of caffeic acid and 3,4-dihydroxyphenyllactic acid. Known for its antioxidant, anti-inflammatory, and antimicrobial properties, rosmarinic acid is explored for cognitive enhancement, neuroprotection, skin health improvement, and mood disorder treatment. It exhibits strong antioxidant activity and modulates biochemical pathways relevant to neurodegeneration and skin aging. Research includes preclinical studies and emerging clinical trials, with systematic reviews focusing on rosemary extracts containing rosmarinic acid. It is available in standardized rosemary extract capsules or supplements.
Benefits
Rosmarinic acid offers several evidence-based benefits. It significantly improves cognitive function, as demonstrated in animal models with moderate to large effect sizes. In humans, it reduces anxiety and depression scores when used as an adjunct to SSRIs in adults with major depressive disorder. Additionally, it improves skin health by reducing dullness, roughness, erythema, and pore size. These benefits are attributed to its anti-inflammatory and antioxidant effects, which contribute to neuroprotection and skin anti-aging. It may also modulate gut microbiota and increase GLP-1 secretion, suggesting potential metabolic benefits. These benefits are observed in adults with cognitive impairment or neurodegenerative risk, patients with major depressive disorder, and individuals seeking skin health improvements.
How it works
Rosmarinic acid primarily works through its antioxidant activity, neutralizing reactive oxygen species (ROS). It also exerts anti-inflammatory effects by inhibiting pro-inflammatory cytokines and pathways. Its neuroprotective properties stem from modulating signaling pathways implicated in neurodegeneration, such as Nrf2 activation. Additionally, it inhibits the formation of advanced glycation end-products (AGEs), which are relevant to skin aging. Rosmarinic acid interacts with the central nervous system to enhance cognitive function and regulate mood, the skin to reduce oxidative stress and glycation-related damage, and the gastrointestinal system to modulate microbiota and incretin hormone secretion (GLP-1).
Side effects
Rosmarinic acid is generally well-tolerated in clinical studies, with no serious adverse events reported in RCTs. Common side effects, occurring in more than 5% of users, include mild gastrointestinal discomfort. Uncommon side effects, affecting 1-5% of users, may include transient gastrointestinal symptoms such as nausea or bloating. Rare side effects, occurring in less than 1% of users, are not significantly documented in reviewed studies. No major drug interactions have been reported, but caution is advised when combined with SSRIs due to potential additive effects on mood. There are no specifically identified contraindications, but standard caution is advised during pregnancy and lactation due to limited data. Safety in children and pregnant women is not well established.
Dosage
The minimum effective dose of rosmarinic acid is approximately 42 mg daily, as used in a clinical RCT. Optimal dosage ranges appear to be between 40-100 mg/day in clinical settings, although higher doses have been used in animal studies. The maximum safe dose is not well defined, but no toxicity has been reported at studied doses. For mood disorders, twice-daily dosing has been used in clinical trials. It is typically administered in standardized rosemary extract capsules or supplements containing quantified rosmarinic acid. Co-administration with food may enhance absorption. It is often combined with other antioxidants or botanical cofactors for synergistic effects.
FAQs
Is rosmarinic acid safe for long-term use?
Limited long-term human data exists, but short- to medium-term use (up to 12 weeks) appears safe and well-tolerated in studies. More research is needed to confirm long-term safety.
Can it be used with antidepressants?
Yes, rosmarinic acid can be used as adjunctive therapy with SSRIs, but it should be done under medical supervision due to potential additive effects on mood.
How soon can benefits be expected?
Mood improvements may be noticeable within 8 weeks, while skin benefits may appear within 12 weeks. Cognitive effects depend on the specific condition and duration of use.
Is isolated rosmarinic acid more effective than whole rosemary extract?
Most evidence is based on rosemary extracts containing rosmarinic acid. The effects of isolated rosmarinic acid require further direct clinical validation to determine its efficacy.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8851910/ – This systematic review and meta-analysis of animal studies found that *Rosmarinus officinalis* administration significantly improved cognitive performance in rodents, with moderate to large effects on memory tasks. The study included multiple RCTs on rodents with cognitive deficits and used a random-effects model to assess heterogeneity.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8772720/ – This review focuses on the therapeutic potential of carnosic acid and rosmarinic acid in Alzheimer's and Parkinson's diseases. It summarizes molecular mechanisms and preclinical evidence supporting neuroprotection, highlighting the need for more clinical trials to validate these findings in humans.
- https://jcadonline.com/safety-effiacy-dietary-supplemet-aging-skin/ – This double-blind, placebo-controlled trial demonstrated that a rosemary extract supplement reduced skin dullness, roughness, erythema, and pore size after 12 weeks. The supplement was well-tolerated, with only mild gastrointestinal side effects reported, suggesting its potential as a skin health aid.
- https://www.mdpi.com/2218-1989/13/9/974 – This study explores the metabolic benefits of rosmarinic acid, particularly its modulation of gut microbiota and increased GLP-1 secretion in high-fat diet contexts. The findings suggest potential therapeutic applications in managing metabolic disorders through these mechanisms.
- https://www.naturalhealthresearch.org/rosemary-supplementation-as-an-adjunctive-therapy-to-ssris-reduces-anxiety-and-depression-symptoms/ – This randomized controlled trial found that rosemary supplementation (42 mg RA daily) adjunctive to SSRIs significantly reduced anxiety and depression scores over 8 weeks in adults with major depressive disorder. The study's findings suggest that rosemary supplementation may be a beneficial adjunctive therapy for managing mood disorders.
